Haroutiunian S - Search Results

1

Cost and comorbidities associated with opioid abuse in managed care and Medicaid patients in the United Stated: a comparison of two recently published studies.

Ghate SR, Haroutiunian S, Winslow R, McAdam-Marx C. Ghate SR, et al. Among authors: haroutiunian s. J Pain Palliat Care Pharmacother. 2010 Sep;24(3):251-8. doi: 10.3109/15360288.2010.501851. J Pain Palliat Care Pharmacother. 2010. PMID: 20718646

2

The challenge of pain management in patients with myasthenia gravis.

Haroutiunian S, Lecht S, Zur AA, Hoffman A, Davidson E. Haroutiunian S, et al. J Pain Palliat Care Pharmacother. 2009;23(3):242-60. doi: 10.1080/15360280903098523. J Pain Palliat Care Pharmacother. 2009. PMID: 19670021 Review.

3

Development and validation of shortened, restructured Treatment Outcomes in Pain Survey instrument (the S-TOPS) for assessment of individual pain patients' health-related quality of life.

Haroutiunian S, Donaldson G, Yu J, Lipman AG. Haroutiunian S, et al. Pain. 2012 Aug;153(8):1593-1601. doi: 10.1016/j.pain.2012.03.010. Epub 2012 Apr 13. Pain. 2012. PMID: 22503221

4

The neuropathic component in persistent postsurgical pain: a systematic literature review.

Haroutiunian S, Nikolajsen L, Finnerup NB, Jensen TS. Haroutiunian S, et al. Pain. 2013 Jan;154(1):95-102. doi: 10.1016/j.pain.2012.09.010. Pain. 2013. PMID: 23273105 Review.

5

Open-label, add-on study of tetrahydrocannabinol for chronic nonmalignant pain.

Haroutiunian S, Rosen G, Shouval R, Davidson E. Haroutiunian S, et al. J Pain Palliat Care Pharmacother. 2008;22(3):213-7. doi: 10.1080/15360280802251215. J Pain Palliat Care Pharmacother. 2008. PMID: 19042851 Clinical Trial.

6

Methadone for chronic non-cancer pain in adults.

Haroutiunian S, McNicol ED, Lipman AG. Haroutiunian S, et al. Cochrane Database Syst Rev. 2012 Nov 14;11(11):CD008025. doi: 10.1002/14651858.CD008025.pub2. Cochrane Database Syst Rev. 2012. PMID: 23152251 Free PMC article. Review.

7

High-dose bupivacaine remotely loaded into multivesicular liposomes demonstrates slow drug release without systemic toxic plasma concentrations after subcutaneous administration in humans.

Davidson EM, Barenholz Y, Cohen R, Haroutiunian S, Kagan L, Ginosar Y. Davidson EM, et al. Among authors: haroutiunian s. Anesth Analg. 2010 Apr 1;110(4):1018-23. doi: 10.1213/ANE.0b013e3181d26d2a. Anesth Analg. 2010. PMID: 20357145 Clinical Trial.

8

Phantom limb pain: treatment strategies.

Nikolajsen L, Christensen KF, Haroutiunian S. Nikolajsen L, et al. Among authors: haroutiunian s. Pain Manag. 2013 Nov;3(6):421-4. doi: 10.2217/pmt.13.51. Pain Manag. 2013. PMID: 24654895 No abstract available.

9

Valproic acid plasma concentration decreases in a dose-independent manner following administration of meropenem: a retrospective study.

Haroutiunian S, Ratz Y, Rabinovich B, Adam M, Hoffman A. Haroutiunian S, et al. J Clin Pharmacol. 2009 Nov;49(11):1363-9. doi: 10.1177/0091270009334377. Epub 2009 Sep 22. J Clin Pharmacol. 2009. PMID: 19773524

10

Topical NSAID therapy for musculoskeletal pain.

Haroutiunian S, Drennan DA, Lipman AG. Haroutiunian S, et al. Pain Med. 2010 Apr;11(4):535-49. doi: 10.1111/j.1526-4637.2010.00809.x. Epub 2010 Mar 4. Pain Med. 2010. PMID: 20210866 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results